DK474189A - Monoklonalt antistof - Google Patents

Monoklonalt antistof Download PDF

Info

Publication number
DK474189A
DK474189A DK474189A DK474189A DK474189A DK 474189 A DK474189 A DK 474189A DK 474189 A DK474189 A DK 474189A DK 474189 A DK474189 A DK 474189A DK 474189 A DK474189 A DK 474189A
Authority
DK
Denmark
Prior art keywords
monoclonal antibody
monoclonal
antibody
Prior art date
Application number
DK474189A
Other languages
Danish (da)
English (en)
Other versions
DK474189D0 (da
Inventor
Susumu Iwasa
Tomofumi Kurokawa
Yukio Toyoda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of DK474189D0 publication Critical patent/DK474189D0/da
Publication of DK474189A publication Critical patent/DK474189A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46—Hybrid immunoglobulins
    • C07K16/468—Immunoglobulins having two or more different antigen binding sites, e.g. multifunctional antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • A61K47/6815—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
    • A61K47/6875—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin
    • A61K47/6879—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site the antibody being a hybrid immunoglobulin the immunoglobulin having two or more different antigen-binding sites, e.g. bispecific or multispecific immunoglobulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK474189A 1988-09-27 1989-09-26 Monoklonalt antistof DK474189A (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP24354488 1988-09-27
JP30192588 1988-11-28
JP6294089 1989-03-14
JP16487389 1989-06-27
JP20893689A JP3177776B2 (ja) 1988-09-27 1989-08-11 ハイブリッドモノクローナル抗体，抗体産生ポリドーマおよび抗体含有薬剤

Publications (2)

Publication Number Publication Date
DK474189D0 DK474189D0 (da) 1989-09-26
DK474189A true DK474189A (da) 1990-03-28

Family

ID=27523741

Family Applications (1)

Application Number Title Priority Date Filing Date
DK474189A DK474189A (da) 1988-09-27 1989-09-26 Monoklonalt antistof

Country Status (15)

Country Link
US (1) US5506135A (fi)
EP (1) EP0363712B1 (fi)
JP (1) JP3177776B2 (fi)
KR (1) KR900004351A (fi)
CN (1) CN1041783A (fi)
AR (1) AR242832A1 (fi)
AT (1) ATE140930T1 (fi)
AU (1) AU628857B2 (fi)
DE (1) DE68926899T2 (fi)
DK (1) DK474189A (fi)
FI (1) FI894551A (fi)
HU (1) HUT55445A (fi)
IL (1) IL91649A (fi)
NO (1) NO893818L (fi)
PT (1) PT91808B (fi)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068322A1 (en) * 1988-04-18 2003-04-10 Immunomedics, Inc. Methods of antibody-directed enzyme-prodrug therapy
TW212184B (fi) * 1990-04-02 1993-09-01 Takeda Pharm Industry Co Ltd
JPH0576385A (ja) * 1990-12-18 1993-03-30 Takeda Chem Ind Ltd キメラ抗体およびその用途
WO1992019973A1 (en) * 1991-04-26 1992-11-12 Surface Active Limited Novel antibodies, and methods for their use
WO2015053381A1 (ja) * 2013-10-10 2015-04-16 幸成 加藤 抗ポドプラニン抗体
EP3620471A4 (en) * 2017-05-02 2021-01-06 National Cancer Center Japan ANTIBODY-ANTI-FIBRIN DRUG CONJUGATE INSOLUBLE, POSSIBLE TO BE CLIVID BY PLASMINE

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4714681A (en) * 1981-07-01 1987-12-22 The Board Of Reagents, The University Of Texas System Cancer Center Quadroma cells and trioma cells and methods for the production of same
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
CA1213229A (en) * 1982-04-12 1986-10-28 Gary S. David Antibodies having dual specificities, their preparation and uses therefor
US4916070A (en) * 1986-04-14 1990-04-10 The General Hospital Corporation Fibrin-specific antibodies and method of screening for the antibodies
JP2635343B2 (ja) * 1986-04-14 1997-07-30 ザ・ジェネラル・ホスピタル・コーポレーション ヘテロ二官能性抗体および利用方法

Also Published As

Publication number Publication date
CN1041783A (zh) 1990-05-02
JP3177776B2 (ja) 2001-06-18
US5506135A (en) 1996-04-09
DE68926899T2 (de) 1997-01-02
AR242832A1 (es) 1993-05-31
PT91808A (pt) 1990-03-30
EP0363712B1 (en) 1996-07-31
KR900004351A (ko) 1990-04-12
PT91808B (pt) 1995-05-31
FI894551A (fi) 1990-03-28
NO893818L (no) 1990-03-28
FI894551A0 (fi) 1989-09-26
ATE140930T1 (de) 1996-08-15
DK474189D0 (da) 1989-09-26
EP0363712A3 (en) 1990-08-16
AU4174789A (en) 1990-04-05
EP0363712A2 (en) 1990-04-18
IL91649A (en) 1994-10-21
IL91649A0 (en) 1990-04-29
AU628857B2 (en) 1992-09-24
NO893818D0 (no) 1989-09-26
HUT55445A (en) 1991-05-28
JPH03103175A (ja) 1991-04-30
DE68926899D1 (de) 1996-09-05

Similar Documents

Publication Publication Date Title
DK666389A (da) Monoklonalt antistof
DE68914244D1 (de) Monoklonaler Antikörper.
DE3879452D1 (de) Chimaere antikoerper.
DE3885355D1 (de) Monoklonale Antikörper.
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
DK188185A (da) Monoklonalt antistof
DK190889A (da) Antigen
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
DK717888A (da) Monoklonale antistoffer
DE3780256D1 (de) Anti-pci-monoklonaler antikoerper.
DK37785D0 (da) Monoclonalt antistof
DK144485D0 (da) Monoklonale antistoffer
DK474189A (da) Monoklonalt antistof
NO890116D0 (no) Monoklonale antistoffer.
NO873488D0 (no) Monoklonale antistoffer.
DK413389D0 (da) Monoklonale antistoffer
DK370089A (da) Anti-urokinase monoklonale antistoffer
DE69023717D1 (de) Monoklonaler Antikörper.
DK220688D0 (da) Monoklonalt antistof
DE68916088D1 (de) Anti-CPBII-monoklonaler Antikörper.
DK240286D0 (da) Monoklonale antistoffer
DK554986D0 (da) Antistof
DK594189D0 (da) Anti-hcg-antistoffer
DE69324928D1 (de) Monoklonaler antikörper
FI923418A0 (fi) Monoklonaalinen vasta-aine

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment